Alamar Biosciences, Inc. Common Stock (ALMR)

Alamar Biosciences, Inc. Common Stock (ALMR) is a Medical Devices company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2B; returns 1 day +3.3%, 1 week +21.4%.

Alamar Biosciences is a commercial-stage life sciences company specializing in precision proteomics and high-sensitivity protein analysis. The company's primary economic driver is its proprietary NULISA (Nucleic Acid Linked Immuno-Sandwich Assay) technology, which enables the detection of protein biomarkers at ultra-low concentrations (single-digit attomolar levels) in biofluids like blood.

Groups ALMR belongs to

• Recent IPOs
• Life Sciences Tools & Services
• Commercial Stage
• Life Sciences
• Health Diagnostics and Imaging
• Precision Medicine
• Biotechnology
• Healthcare Technology
• Alzheimer's Disease
• Healthcare Innovation

ALMR financial model: income statement, cash flow and balance sheet